Brand | Abnova |
Product type | Primary antibodies |
Host species | Rabbit |
Applications | ELISA,WB-Tr |
Brand: | Abnova |
Reference: | PAB10208 |
Product name: | Matrix Protein p15 polyclonal antibody |
Product description: | Rabbit polyclonal antibody raised against synthetic peptide of Matrix Protein p15. |
Immunogen: | A synthetic peptide corresponding to internal region of Feline Immunodeficiency Virus Matrix Protein p15. |
Protein accession: | P16087;P16087 |
Form: | Liquid |
Recommend dilutions: | ELISA (1:5000-1:20000) Western Blot (1:1000-1:10000) The optimal working dilution should be determined by the end user. |
Storage buffer: | In 20 mM KH2PO4, 150 mM NaCl, pH 7.2 (0.01% sodium azide) |
Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Rabbit |
Antigen species / target species: | Viruses |
Specificity: | This affinity purified antibody is directed against Feline Immunodeficiency Virus (FIV) Matrix Protein p15. |
Application image: | ![]() |
Application image note: | Western blot using Matrix Protein p15 polyclonal antibody (Cat # PAB10208) to detect p15 in the culture supernatant of FIV-infected feline CrFK cells (Lane 2, arrowhead). Lane 1 is an uninfected control. Virions were enriched by ultracentrifugation, lysed, resolved by electrophoresis, and transferred to nitrocellulose. The membrane was probed with the primary antibody at a 1:10,000 dilution. Personal Communication, B. Luttge, CCR-NCI, Frederick, MD. |
Applications: | ELISA,WB-Tr |
Shipping condition: | Dry Ice |
Publications: | Nucleotide sequence and genomic organization of feline immunodeficiency virus.Talbott RL, Sparger EE, Lovelace KM, Fitch WM, Pedersen NC, Luciw PA, Elder JH. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5743-7. |